Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical Study (Forbes Breaking News)

On Friday, Pfizer announced that an interim analysis of clinical trial data found that its antiviral pill to treat Covid, Paxlovid, reduces the risk of hospitalization and death from Covid by 89% compared to a placebo.

READ MORE:
https://www.forbes.com/sites/alexknapp/2021/11/05/pfizer-says-its-covid-pill-reduced-risk-of-hospitalization-and-death-by-89-in-clinical-study/?sh=7ec92fce56be

Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical Study